CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: March 27, 2009
Result type: Reports
Project Number: S0163
Product Line: Common Drug Review

Generic Name: Darunavir

Brand Name: Prezista

Manufacturer: Janssen-Ortho Inc.

Indications: HIV (treatment naive)

Submission Type: New Indication

Project Status: Complete

Date Recommendation Issued: October 14, 2009

Recommendation Type: List with clinical criteria and/or conditions